1. Home
  2. AUID vs EVAX Comparison

AUID vs EVAX Comparison

Compare AUID & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo authID Inc.

AUID

authID Inc.

HOLD

Current Price

$0.96

Market Cap

35.6M

Sector

Technology

ML Signal

HOLD

EVAX

Evaxion Biotech

HOLD

Current Price

$5.20

Market Cap

42.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUID
EVAX
Founded
2009
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.6M
42.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
AUID
EVAX
Price
$0.96
$5.20
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$12.33
AVG Volume (30 Days)
388.8K
110.8K
Earning Date
11-12-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,834,458.00
$7,650,000.00
Revenue This Year
N/A
$128.77
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
141.81
132.17
52 Week Low
$0.87
$1.20
52 Week High
$9.58
$12.15

Technical Indicators

Market Signals
Indicator
AUID
EVAX
Relative Strength Index (RSI) 32.48 44.84
Support Level $0.87 $4.60
Resistance Level $1.05 $6.70
Average True Range (ATR) 0.11 0.54
MACD 0.03 -0.12
Stochastic Oscillator 14.82 21.55

Price Performance

Historical Comparison
AUID
EVAX

About AUID authID Inc.

AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

Share on Social Networks: